Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Principal Investigator was leaving the institution.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| irritable bowel disease patient | Patients with ulcerative proctitis and proctosigmoiditis who meet the inclusion criteria, they will have ECG recording, inflammatory cytokines, microbiota, ulcerative colitis disease activity index. |
| |
| healthy control | Healthy participates who meet the inclusion criteria, they will have ECG recording, inflammatory cytokines, microbiota, ulcerative colitis disease activity index. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ECG recording, inflammatory cytokines, microbiota, ulcerative colitis disease activity index | Other | In this study, an electrocardiogram signal will be recorded for 30 min in the fasting state, and blood samples for inflammatory cytokines analysis (7 ml) will be taken at the end of the ECG recording; fecal samples will be taken on the experimental day before the study. In addition, ulcerative colitis disease activity index will be assessed using the Mayo scoring system. |
| Measure | Description | Time Frame |
|---|---|---|
| symptoms characteristics in ulcerative colitis patients | ulcerative colitis disease activity index will be assessed using the Mayo scoring system, which includes stool frequency, rectal bleeding, mucosal appearance at endoscopy and physician rating of disease activity. The patient will get a score from 0 to 20, with higher score indicating more severe disease. | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| autonomic profile characteristics in ulcerative colitis patients and healthy controls | heart rate variability indicating sympathetic and parasympathetic activity | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
irritable bowel disease patients and healthy controls.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jiande Chen, PhD | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins University | Baltimore | Maryland | 21224 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015212 | Inflammatory Bowel Diseases |
| ID | Term |
|---|---|
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D007410 | Intestinal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D064307 | Microbiota |
| ID | Term |
|---|---|
| D008827 | Microbiological Phenomena |
| D058448 | Biota |
| D044822 | Biodiversity |
| D017753 | Ecosystem |
Not provided
Not provided
Not provided
Not provided
Not provided
blood sample for inflammatory cytokines, fecal sample for microbiota
|
blood sample, Granulocyte-colony stimulating factor (G-CSF) |
| 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Eotaxin | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Granulocyte-macrophage colony-stimulating factor (GM-CSF) | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -1α | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Leptin | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Macrophage Inflammatory Proteins (MIP) -1α | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -4 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -1β | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -2 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -6 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Epidermal growth factor (EGF) | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -13 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -10 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -12p70 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Interferon gamma (IFNγ) | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -5 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -17A | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, interleukin (IL) -18 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Monocyte Chemoattractant Protein-1 (MCP-1) | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Interferon - induced protein 10 (IP-10), | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, growth regulated oncogene (GRO)/Keratinocyte chemoattractant KC/cytokine-induced neutrophil chemoattractant (CINC)-1 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Vascular endothelial growth factor (VEGF) | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Fractalkine | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Lipopolysaccharide-induced CXC chemokine (LIX) | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Macrophage Inflammatory Proteins (MIP) -2 | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, Tumor necrosis factor (TNF) α | 1 day |
| inflammatory cytokine profile in ulcerative colitis patients and healthy controls | blood sample, RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) | 1 day |
| microbiota profile in ulcerative colitis patients and healthy controls | fecal sample microbiota analysis | 1 day |
| D004777 |
| Environment |
| D055669 | Ecological and Environmental Phenomena |
| D001686 | Biological Phenomena |
| D004778 | Environment and Public Health |